Ernexa Therapeutics Inc. financial data

Symbol
ERNA on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 70% % -1.4%
Debt-to-equity 540% %
Return On Equity -1949% % -697%
Return On Assets -305% % -159%
Operating Margin -2693% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7,848,889 shares -85%
Common Stock, Shares, Outstanding 7,849,000 shares 45%
Entity Public Float $8,900,000 USD -8.2%
Common Stock, Value, Issued $39,000 USD 44%
Weighted Average Number of Shares Outstanding, Basic 8,226,000 shares 2179%
Weighted Average Number of Shares Outstanding, Diluted 8,226,000 shares 2179%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $582,000 USD
Cost of Revenue $96,000 USD
General and Administrative Expense $5,284,000 USD -67%
Operating Income (Loss) $9,921,000 USD 47%
Nonoperating Income (Expense) $8,391,000 USD 68%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $18,312,000 USD 59%
Income Tax Expense (Benefit) $28,000 USD 87%
Net Income (Loss) Attributable to Parent $18,340,000 USD 59%
Earnings Per Share, Basic 86 USD/shares 100%
Earnings Per Share, Diluted 86 USD/shares 100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,315,000 USD 67%
Assets, Current $3,379,000 USD -29%
Property, Plant and Equipment, Net $92,000 USD -12%
Operating Lease, Right-of-Use Asset $541,000 USD -25%
Goodwill $2,044,000 USD 0%
Other Assets, Noncurrent $116,000 USD -3.3%
Assets $6,172,000 USD -20%
Accounts Payable, Current $958,000 USD -56%
Employee-related Liabilities, Current $12,000 USD -89%
Accrued Liabilities, Current $859,000 USD -26%
Contract with Customer, Liability, Current $5,335,000 USD
Liabilities, Current $2,144,000 USD -78%
Operating Lease, Liability, Noncurrent $346,000 USD -35%
Other Liabilities, Noncurrent $112,000 USD 33%
Liabilities $2,602,000 USD -95%
Retained Earnings (Accumulated Deficit) $244,126,000 USD -8.1%
Stockholders' Equity Attributable to Parent $3,570,000 USD
Liabilities and Equity $6,172,000 USD -20%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,065,000 USD 45%
Net Cash Provided by (Used in) Financing Activities $2,254,000 USD 63%
Net Cash Provided by (Used in) Investing Activities $97,000 USD
Common Stock, Shares Authorized 150,000,000 shares 50%
Common Stock, Shares, Issued 7,849,000 shares 45%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3,047,000 USD -29%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $26,023,000 USD 42%
Deferred Tax Assets, Gross $26,347,000 USD -10%
Operating Lease, Liability $552,000 USD -25%
Payments to Acquire Property, Plant, and Equipment $101,000 USD
Lessee, Operating Lease, Liability, to be Paid $625,000 USD -27%
Property, Plant and Equipment, Gross $257,000 USD -58%
Operating Lease, Liability, Current $206,000 USD 2.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two $200,000 USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year One $304,000 USD 11%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 20%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $73,000 USD -39%
Lessee, Operating Lease, Liability, to be Paid, Year Three $95,000 USD -42%
Preferred Stock, Shares Issued 156,000 shares 0%
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Unrecognized Tax Benefits $393,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $82,000 USD -99%
Additional Paid in Capital $247,656,000 USD 37%
Preferred Stock, Shares Outstanding 156,000 shares 0%
Depreciation, Depletion and Amortization $18,000 USD -54%
Deferred Tax Assets, Net of Valuation Allowance $324,000 USD -97%
Share-based Payment Arrangement, Expense $1,573,000 USD 23%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%